Latest fund size
$200M
Announced
November 10, 2026
Global HQ
Hong Kong
Members only
Check size
$5M-$10M
Members only
Stage focus
Series A, Series B, Series C+
Members only
Regions of investment
Asia, North America
Members only
Aulis Capital is a global investment firm focused on life sciences and healthcare, founded by Nisa Leung, previously Managing Partner at Qiming Venture Partners, where she built and led the firm's healthcare practice starting in 2006. Aulis Capital operates from Hong Kong and California and backs entrepreneurs and technologies aimed at improving patient outcomes across Western and Asian biotech markets.
Nisa Leung, Founding Managing Partner
Pamela Carroll, Venture Partner
Brian Zhu, Vice President
Mingyu Xue, Ph.D., Principal
Helen Siaw, Investor
Paul Li, Venture Partner
Franck Le Deu, Venture Partner
Ethan Than, Venture Partner
Members only
Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.
Aulis Capital partners with early- and growth-stage life sciences and healthcare companies, with a thesis centered on cross-border biotech that bridges Western and Asian innovation.
The firm backs technologies that improve patient outcomes, combining scientific depth, analytical rigor, and investment expertise, with a particular focus on China as a source of globally valuable biopharma innovation.
Members only
What the fund looks for in founders and which sectors it backs.
Aulis Capital announced the final close of Aulis Capital Fund I, L.P., its inaugural fund, in November 2026, with $200 million in total capital commitments.
LP information beyond the firm's public thanks to its limited partners was not disclosed.
Members only
Fund size, LPs and track record.
Leadership
Investment Strategy
The firm combines scientific depth, analytical rigor, and investment expertise, drawing on more than 20 years of experience in technology and healthcare to back visionary entrepreneurs across early- and growth-stage rounds.
Notable Investments
Members only
Leadership, investment strategy, notable investments and exits.
